UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Annals of oncology, 2019-01, Vol.30 (1), p.68-75

2019

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer

Annals of oncology, 2019-03, Vol.30 (3), p.431-438

2019

Link zum Volltext

Verfügbarkeit prüfen

2OA phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors

Annals of oncology, 2019-02, Vol.30 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

45PCircular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Link zum Volltext

Verfügbarkeit prüfen

1899PThe clinical and transcriptional signatures of human CD204 reveal an applicable marker for tumor associated macrophage in breast cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

483PPopulation pharmacokinetics of tislelizumab in patients with advanced tumors

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

50PReduced-, and no-dose thin-section radiologic examinations: Comparison of capability for nodule detection in patients having pulmonary nodules

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Link zum Volltext

Verfügbarkeit prüfen

104PEpigenetic markers in circulating cell-free DNA for detection of early stage colorectal cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

548PLocal immune status in cancer cell nests can be a predictor of survival for rectal cancer with neoadjuvant radiotherapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

1747PHigh-biologically effective dose radiotherapy improve the survival of small cell lung cancer patients with brain metastases: A propensity-matching analysis

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

1471PEGFR inhibitor versus chemotherapy as adjuvant treatment for locally-advanced EGFR-mutant non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

415PTrends in incidence and survival analyses of adult-onset medulloblastoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

1722PIn vivo efficacy and enhanced tumour accumulation of liposomal vinorelbine (TLC178) in human sarcoma xenograft mice model

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

459PDLong-term results of postoperative chemoradiation therapy with capecitabine and oxaliplatin versus capecitabine alone for locally advanced rectal cancer: A randomized, multicenter, phase III trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

45P3D association of ER, PR and HER2 to aid sub-grouping of breast cancer patients

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Link zum Volltext

Verfügbarkeit prüfen

1032PPhase I study of low dose whole abdominal radiation therapy (LDWART) in combination with weekly paclitaxel (wP) for platinum resistant ovarian cancer (PROC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

LBA31Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases: A single center randomized control trial

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

205PHepatitis B screening and incidence of flare among non-metastatic breast cancer patients treated with anthracyclines

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

636PSurvival benefit of re-irradiation in esophageal cancer patients with locoregional recurrence: A propensity score matched analysis

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

504PAssociation of systemic and local inflammation with prognosis in rectal cancer treated with neoadjuvant radiotherapy

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

1598PReferral patterns and predictors of survival for stage IV pancreatic ductal adenocarcinoma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

502PComparison of immune microenvironment between different neoadjuvant radiotherapy regimens for rectal cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

1337PPredictive models for CEUS of the breast: Is it feasible in improved performance of BI-RADS evaluation of critical breast lesions?

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

496PShort-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): A planned interim analysis

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

653PPD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

KollektionIngenta

Zeitschrift / SerieAnnals Of Oncology

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer

2OA phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors

45PCircular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s

1899PThe clinical and transcriptional signatures of human CD204 reveal an applicable marker for tumor associated macrophage in breast cancer

483PPopulation pharmacokinetics of tislelizumab in patients with advanced tumors

50PReduced-, and no-dose thin-section radiologic examinations: Comparison of capability for nodule detection in patients having pulmonary nodules

104PEpigenetic markers in circulating cell-free DNA for detection of early stage colorectal cancer

548PLocal immune status in cancer cell nests can be a predictor of survival for rectal cancer with neoadjuvant radiotherapy

1747PHigh-biologically effective dose radiotherapy improve the survival of small cell lung cancer patients with brain metastases: A propensity-matching analysis

1471PEGFR inhibitor versus chemotherapy as adjuvant treatment for locally-advanced EGFR-mutant non-small cell lung cancer

415PTrends in incidence and survival analyses of adult-onset medulloblastoma

1722PIn vivo efficacy and enhanced tumour accumulation of liposomal vinorelbine (TLC178) in human sarcoma xenograft mice model

459PDLong-term results of postoperative chemoradiation therapy with capecitabine and oxaliplatin versus capecitabine alone for locally advanced rectal cancer: A randomized, multicenter, phase III trial

45P3D association of ER, PR and HER2 to aid sub-grouping of breast cancer patients

1032PPhase I study of low dose whole abdominal radiation therapy (LDWART) in combination with weekly paclitaxel (wP) for platinum resistant ovarian cancer (PROC)

LBA31Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases: A single center randomized control trial

205PHepatitis B screening and incidence of flare among non-metastatic breast cancer patients treated with anthracyclines

636PSurvival benefit of re-irradiation in esophageal cancer patients with locoregional recurrence: A propensity score matched analysis

504PAssociation of systemic and local inflammation with prognosis in rectal cancer treated with neoadjuvant radiotherapy

1598PReferral patterns and predictors of survival for stage IV pancreatic ductal adenocarcinoma

502PComparison of immune microenvironment between different neoadjuvant radiotherapy regimens for rectal cancer

1337PPredictive models for CEUS of the breast: Is it feasible in improved performance of BI-RADS evaluation of critical breast lesions?

496PShort-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): A planned interim analysis

653PPD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)

Aktive Filter

Suchergebnisse filtern